| Trial ID: | L0178 |
| Source ID: | NCT04616014
|
| Associated Drug: |
Insulin
|
| Title: |
A Study of Oral Insulin to Reduce Liver Fat Content in Type 2 Diabetes Patients With Nonalcoholic Steatohepatitis (NASH)
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Steatohepatitis (NASH)
|
| Interventions: |
Drug: ORMD-0801 QD|Drug: ORMD-0801 BD
|
| Outcome Measures: |
Number of participants with treatment-related adverse events.|Percent change in liver fat content|Percent change in liver fibrosis|Percent change in liver steatosis
|
| Sponsor/Collaborators: |
Oramed, Ltd.
|
| Gender: |
All
|
| Age: |
18 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
40
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
March 1, 2021
|
| Completion Date: |
March 2022
|
| Results First Posted: |
--
|
| Last Update Posted: |
January 10, 2022
|
| Locations: |
Universitaire Ziekenhuis Gent, Gent, Belgium
|
| URL: |
https://ClinicalTrials.gov/show/NCT04616014
|
